Combination therapy of an anti CD20 antibody with a BTK inhibitor

• 收藏
• 分享

专利权人:

F. Hoffmann-La Roche AG;Ono Pharmaceutical Co., Ltd.

发明人:

Klein, Christian,Toshio, Yoshizawa,Tomoko, Yasuhiro

申请号：

AU2014345712

公开号：

AU2014345712A1

申请日:

2014.11.04

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

The present invention is directed to the combination therapy of an anti-CD20 antibody with a BTK inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with a type I anti-CD20 antibody or an afucosylated humanized B-Lyl antibody and a BTK inhibitor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/